Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting 2.37. At the close of trading, the stock’s price was $0.54, to imply a decrease of -4.16% or -$0.02 in intraday trading. The CDT share’s 52-week high remains $350.00, putting it -64714.81% down since that peak but still an impressive 5.56% since price per share fell to its 52-week low of $0.51. The company has a valuation of $6.09M, with an average of 0.71 million shares in intraday trading volume over the past 10 days and average of 5.61 million shares over the past 3 months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
After registering a -4.16% downside in the last session, Conduit Pharmaceuticals Inc (CDT) has traded red over the past five days. The 5-day price performance for the stock is -4.59%, and -28.14% over 30 days. With these gigs, the year-to-date price performance is -92.18%. Short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) saw shorts transact 1.58 million shares and set a 0.24 days time to cover.
CDT Dividends
Conduit Pharmaceuticals Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Conduit Pharmaceuticals Inc insiders hold 6.67% of total outstanding shares, with institutional holders owning 0.72% of the shares at 0.77% float percentage. In total, 0.72% institutions holds shares in the company, led by BARCLAYS PLC. As of 2024-06-30, the company held over 0.81 million shares (or 0.022% of shares), all amounting to roughly $0.86 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 0.69 million shares, or about 0.0187% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.73 million.
We also have Fidelity Salem Street Trust-Fidelity Small Cap Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Conduit Pharmaceuticals Inc (CDT) shares. Going by data provided on Feb 28, 2025 , Fidelity Salem Street Trust-Fidelity Small Cap Index Fund holds roughly 12.82 shares. This is just over 0.12% of the total shares, with a market valuation of $6879.0. Data from the same date shows that the other fund manager holds a little less at 2.03, or 0.02% of the shares, all valued at about 1088.0.
